Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

3.1K
Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult...
3.1K
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

11.6K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
11.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TLR3 activation of microglia-containing cerebral organoid induces antiviral factors against HIV-1 infection.

Frontiers in pharmacology·2026
Same author

Red electroluminescent Cu<sub>4</sub>I<sub>4</sub> bipyramids with external quantum efficiency beyond 40.

Nature communications·2026
Same author

JQKD82 Inhibits HIV Infection of Macrophages Through Blocking Viral Entry and Enhancing Antiviral ISG Responses.

Journal of medical virology·2026
Same author

Biosensors with enzymatic amplification strategies for the detection of foodborne pathogenic microorganisms.

Biotechnology advances·2026
Same author

The Effects of Different Organic Amendment Strategies on Soil Properties and Microbial Communities in Maize Monocropping.

Plants (Basel, Switzerland)·2026
Same author

Characterization and Molecular Modification of a Cold-Adapted β-Galactosidase from <i>Flavobacterium algicola</i> for Preparation of Lactose-Free Milk.

Journal of agricultural and food chemistry·2026

Related Experiment Video

Updated: Dec 19, 2025

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
07:32

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography

Published on: March 30, 2022

5.0K

Inhibiting Matrix Metalloproteinase-2 Activation by Perturbing Protein-Protein Interactions Using a Cyclic Peptide.

Priyanka Sarkar1, Zhonghan Li1, Wendan Ren2

  • 1Department of Chemistry, University of California, Riverside, Riverside, California 92521, United States.

Journal of Medicinal Chemistry
|June 4, 2020
PubMed
Summary

A novel cyclic peptide effectively inhibits matrix metalloproteinase-2 (MMP2) activation by blocking protein-protein interactions. This breakthrough offers a new strategy for MMP2 inhibition, a goal pursued for 20 years.

More Related Videos

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels
07:39

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels

Published on: January 22, 2019

7.7K
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

12.2K

Related Experiment Videos

Last Updated: Dec 19, 2025

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
07:32

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography

Published on: March 30, 2022

5.0K
Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels
07:39

Measuring Global Cellular Matrix Metalloproteinase and Metabolic Activity in 3D Hydrogels

Published on: January 22, 2019

7.7K
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

12.2K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Matrix metalloproteinase-2 (MMP2) is a key enzyme implicated in various physiological and pathological processes.
  • MMP2 activation is a complex process involving its precursor, proMMP2, and tissue inhibitor of metalloproteinases-2 (TIMP2).
  • Targeting MMP2 activation is a long-standing goal for therapeutic intervention.

Purpose of the Study:

  • To develop and characterize a novel cyclic peptide inhibitor of MMP2 activation.
  • To investigate the mechanism of inhibition, focusing on the interaction between proMMP2 and TIMP2.
  • To evaluate the efficacy of the cyclic peptide in a cellular context.

Main Methods:

  • Epitope-targeted library screening to identify the cyclic peptide inhibitor.
  • Biochemical assays to validate binding of the peptide to proMMP2.
  • Cell-based assays using a human melanoma cell line to assess modulation of MMP2 activity and cell migration.

Main Results:

  • A cyclic peptide was developed that inhibits proMMP2 activation with low nM potency.
  • The inhibitor specifically binds to the D570-A583 epitope on proMMP2.
  • The peptide interferes with the proMMP2-TIMP2 protein-protein interaction, preventing TIMP2-assisted activation.
  • The cyclic peptide demonstrated the ability to modulate cellular MMP2 activities and inhibit melanoma cell migration.

Conclusions:

  • This study presents the first successful example of targeting the protein-protein interaction between proMMP2 and TIMP2.
  • The developed cyclic peptide represents a promising therapeutic strategy for MMP2-related conditions.
  • The findings validate the feasibility of inhibiting MMP2 activation through disruption of its interaction with TIMP2.